80978 studies found for:    United States
Show Display Options
Rank Status Study
1 Not yet recruiting Empowered Sisters Project Making Choices Reducing Risks
Conditions: Domestic Violence;   Domestic Abuse
Intervention: Behavioral: Behavioral  - Education
2 Recruiting Eastern Caribbean Health Outcomes Research Network (ECHORN)
Conditions: Cancer;   Cardiovascular Disease;   Diabetes;   Non Communicable Chronic Diseases
Intervention:
3 Active, not recruiting Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Intervention: Drug: OPC-34712 + ADT
4 Active, not recruiting Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Conditions: Childhood Glioblastoma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Gliosarcoma
Interventions: Drug: vorinostat;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Other: laboratory biomarker analysis
5 Active, not recruiting Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib plus dexamethasone;   Drug: Velcade plus dexamethasone
6 Completed A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)
Condition: Recurrent Herpes Labialis
Interventions: Drug: NB-001;   Drug: Vehicle
7 Completed Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo
8 Recruiting Prevention of Serious Adverse Events Following Angiography
Conditions: Acute Renal Failure;   Kidney Disease;   Coronary Artery Disease
Interventions: Drug: IV isotonic saline;   Drug: IV isotonic bicarbonate;   Drug: N-acetylcysteine;   Drug: Placebo
9 Completed
Has Results
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Condition: Bipolar Disorder
Interventions: Drug: Ziprasidone oral capsules;   Drug: placebo oral capsules
10 Active, not recruiting Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: docetaxel;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
11 Completed
Has Results
Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
Conditions: Bipolar Mania;   Bipolar Disorder
Interventions: Drug: Placebo;   Drug: Ziprasidone Oral Capsule
12 Terminated Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: FCR + Lumiliximab;   Drug: FCR
13 Completed Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Procedure: videothoracoscopy
14 Completed
Has Results
Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Vortioxetine;   Drug: Placebo
15 Completed
Has Results
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Drug: topotecan hydrochloride
16 Completed Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals
Condition: HIV Infections
Intervention: Drug: Protease inhibitor tipranavir
17 Recruiting A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 5-11 Years Old With Persistent Asthma
Condition: Asthma
Interventions: Drug: Beclomethasone dipropionate;   Drug: Placebo;   Drug: albuterol/salbutamol 90 mcg
18 Unknown  Study of Irofulven in Patients With Hormone-refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Irofulven + prednisone;   Drug: Irofulven + capecitabine + prednisone;   Drug: Mitoxantrone + prednisone
19 Active, not recruiting Simtuzumab (GS-6624) in the Treatment of Liver Fibrosis in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab 75 mg;   Biological: Simtuzumab 125 mg;   Biological: Placebo
20 Completed S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: methotrexate;   Procedure: allogeneic bone marrow transplantation;   Radiation: radiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years